MiNK Therapeutics
INKT
INKT
22 hedge funds and large institutions have $1.32M invested in MiNK Therapeutics in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$63K | |
| 2 | +$34.5K | |
| 3 | +$22.3K | |
| 4 |
AGWCA
Annis Gardner Whiting Capital Advisors
Tampa,
Florida
|
+$2.23K |
| 5 |
CIAM
Caitong International Asset Management
Hong Kong
|
+$111 |
Top Sellers
| 1 | -$286K | |
| 2 | -$116K | |
| 3 | -$6.33K | |
| 4 |
Citigroup
New York
|
-$2.74K |
| 5 |
HFS
Horizon Financial Services
Winston Salem,
North Carolina
|
-$1.78K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HFS
26
Horizon Financial Services
Winston Salem,
North Carolina
| – |
|
|||
27
Wells Fargo
San Francisco,
California
| – |
|
|||
28
Barclays
London,
United Kingdom
| – |
|